--Novartis AG is considering selling assets including its respiratory and ophthalmology businesses as it seeks to invest in innovative medicines, Bloomberg reports, citing unnamed sources.

--The Swiss pharma major's ophthalmology business alone could be worth about $5 billion, according to Bloomberg.

--Any sales of the businesses are likely to start in 2023 but there is no certainty that the deliberations will result in disposals, Bloomberg reports.

 

Full story: https://bloom.bg/3txZE7V

 

Write to Cecilia Butini at cecilia.butini@wsj.com

 

(END) Dow Jones Newswires

November 16, 2022 10:02 ET (15:02 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Gráfico Histórico do Ativo
De Dez 2022 até Jan 2023 Click aqui para mais gráficos Novartis.
Novartis (NYSE:NVS)
Gráfico Histórico do Ativo
De Jan 2022 até Jan 2023 Click aqui para mais gráficos Novartis.